Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer

T. Masuishi, T. Suzuki, Y. Sukawa, C. K. Imamura, H. Satake, Y. Kumekawa, S. Funakoshi, M. Kotaka, Y. Horie, S. Kawai, H. Okuda, T. Terazawa, C. Kondoh, K. Kato, K. Yoshimura, H. Ishikawa, Y. Hamamoto, N. Boku, T. Kanai, H. Takaishi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)viii156
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
Publication statusPublished - 2018 Oct 1

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Masuishi, T., Suzuki, T., Sukawa, Y., Imamura, C. K., Satake, H., Kumekawa, Y., Funakoshi, S., Kotaka, M., Horie, Y., Kawai, S., Okuda, H., Terazawa, T., Kondoh, C., Kato, K., Yoshimura, K., Ishikawa, H., Hamamoto, Y., Boku, N., Kanai, T., & Takaishi, H. (2018). Prospective evaluation of regorafenib dose escalation strategy with low starting dose in patients with colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii156. https://doi.org/10.1093/annonc/mdy281.015